Dynamics of the HIV-1 latent reservoir after discontinuation of the intensification of antiretroviral treatment-Reference-Cited by-同舟云学术

Dynamics of the HIV-1 latent reservoir after discontinuation of the intensification of antiretroviral treatment

Published:2013-08-24 Issue:13 Volume:27 Page:2081-2088
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Gutiérrez Carolina,Hernández-Novoa Beatriz,Vallejo Alejandro,Serrano-Villar Sergio,Abad-Fernández María,Madrid Nadia,Díaz Laura,Moreno Ana,Dronda Fernando,Zamora Javier,Muñoz-Fernández María Ángeles,Moreno Santiago

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference39 articles.

1. Persistence of episomal HIV-1 infection intermediates in patients on highly active antiretroviral therapy.;Sharkey;Nat Med,2000

2. T cell activation is associated with lower CD4 T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.;Hunt;J Infect Dis,2003

3. Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years.;Havlir;J Virol,2003

4. HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.;Chun;J Clin Invest,2005

5. Short-course raltegravir intensification does not reduce persistent low-level viremia in patients with HIV-1 suppression during receipt of combination antiretroviral therapy.;McMahon;Clin Infect Dis,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why the HIV Reservoir Never Runs Dry: Clonal Expansion and the Characteristics of HIV-Infected Cells Challenge Strategies to Cure and Control HIV Infection;Viruses;2021-12-14

2. Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound;Scientific Reports;2020-12

3. Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment;Journal of Nanobiotechnology;2019-05-21

4. Transient Loss of HIV-1 DNA in an HIV-1 Positive Patient After Kidney Transplantation: A Case Report;The American Journal of Medicine;2018-10

5. Dolutegravir intensification and HIV persistence: 3 + 1 = 3;The Lancet HIV;2018-05